Gold nanoparticle mediated cancer immunotherapy
Joao Paulo Mattos Almeida1, Elizabeth Raquel Figueroa1, Rebekah Anna Drezek1
1Department of Bioengineering, Rice University, Houston, TX, USA.
Nanomedicine : Nanotechnology, Biology, and Medicine
|October 10, 2013
Summary
Gold nanoparticles (AuNP) offer improved cancer immunotherapy by enabling targeted delivery of vaccines and adjuvants, enhancing efficacy and reducing side effects. AuNP also show promise in combination therapies, such as with photothermal ablation.
Area of Science:
- Nanotechnology
- Immunology
- Oncology
Background:
- Cancer immunotherapy is a rapidly advancing field with significant potential for treating malignancies.
- Current immunotherapies face challenges with safety and efficacy due to systemic delivery methods.
- Nanotechnology, specifically gold nanoparticles (AuNP), presents a promising solution for targeted immunotherapy delivery.
Purpose of the Study:
- To provide a critical overview of recent advances in gold nanoparticle (AuNP)-mediated cancer immunotherapies.
- To highlight the advantages of using AuNP as carriers for immunotherapy agents.
- To explore the synergistic potential of AuNP immunotherapies with existing cancer treatments.
Main Methods:
- Review of recent scientific literature on AuNP applications in cancer immunotherapy.
- Analysis of AuNP properties, including biodistribution and optical characteristics, for drug delivery.
- Examination of AuNP's capacity to deliver macromolecules like peptides and oligonucleotides.
Main Results:
- AuNP carriers enhance the targeted delivery of immunotherapy agents to immune cells.
- The use of AuNP improves the therapeutic effect and reduces adverse outcomes of cancer immunotherapy.
- AuNP-based immunotherapies demonstrate suitability for combination therapies, including photothermal ablation.
Conclusions:
- Gold nanoparticles represent a significant advancement in cancer immunotherapy delivery systems.
- AuNP-mediated strategies offer improved safety and efficacy compared to traditional systemic delivery.
- AuNP immunotherapies are well-positioned for synergistic combination treatments, enhancing overall cancer therapy outcomes.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
02:57Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K